Ask Warren

Kbio Labs

038530 · KOSDAQ · ₩038530 · 케이바이오랩스

₩3,015▼ ₩90 (2.90%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩87B₩77B₩27B₩34B₩8.7B
Cost of sales₩75B₩65B₩24B₩29B₩6.8B
Gross profit₩13B₩12B₩3.7B₩5B₩1.9B
Operating income₩1.5B₩793M−₩561M−₩153M−₩4.8B
Net income−₩5B−₩10B−₩13B−₩7.7B−₩19B
Net income to shareholders−₩3.2B−₩6.8B−₩13B−₩7.7B−₩19B

Balance sheet

20252024202320222021
Total assets₩119B₩117B₩143B₩82B₩87B
Current assets₩84B₩71B₩74B₩51B₩65B
Cash and equivalents₩31B₩30B₩48B₩40B₩43B
Total liabilities₩17B₩10B₩15B₩16B₩24B
Current liabilities₩16B₩9.6B₩12B₩16B₩24B
Borrowings₩2.6B₩0₩0₩10B₩19B
Total equity₩102B₩107B₩128B₩67B₩63B
Shareholders' equity₩53B₩56B₩63B₩67B₩63B

Cash flow

20252024202320222021
Cash from operations₩8.2B−₩119M−₩1.5B₩3.8B−₩1.1B
Capital spending₩36M₩71M₩8M₩16M₩93M
Free cash flow₩8.2B−₩190M−₩1.5B₩3.8B−₩1.2B

Consolidated where available. Amounts in won.

Also known as: Kbio Labs / 케이바이오랩스 / 038530 / KRX:038530

Source: KRX statistical information